STOCK TITAN
  1. Home
  2. Sec-filings
  3. VTYX
  4. [SCHEDULE 13G/A] Ventyx Biosciences, Inc. SEC Filing

[SCHEDULE 13G/A] Ventyx Biosciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock VTYX logo
Ventyx Biosciences, Inc.

NASDAQ:VTYX

VTYX Rankings

#4314 Ranked by Market Cap
N/A Ranked by Dividends

VTYX Latest News

Aug 27, 2025
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
Aug 7, 2025
Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Jun 17, 2025
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
May 28, 2025
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
May 8, 2025
Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress

VTYX Latest SEC Filings

Aug 14, 2025
[SCHEDULE 13G/A] Ventyx Biosciences, Inc. SEC Filing
Aug 7, 2025
[8-K] Ventyx Biosciences, Inc. Reports Material Event

VTYX Stock Data

171.14M
68.38M
4.11%
68.24%
6.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO